Covestor LTD Veracyte, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Covestor LTD holds 13 shares of VCYT stock, worth $514. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 22 40.91%

Holding current value

$514

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$21.0 - $35.25 $189 - $317	-9 Reduced 40.91%	13 $0
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $357 - $494	17 Added 340.0%	22 $1,000
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $22 - $29	-1 Reduced 16.67%	5 $0
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $15 - $29	-1 Reduced 14.29%	6 $0
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $16 - $27	-1 Reduced 12.5%	7 $0
Q2 2022 Aug 10, 2022	SELL	$15.45 - $29.52 $46 - $88	-3 Reduced 27.27%	8 $0
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $43 - $85	-2 Reduced 15.38%	11 $0
Q4 2021 Feb 10, 2022	BUY	$36.09 - $53.79 $469 - $699	13 New	13 $1,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account